v3.26.1
Stockholders' Equity (Tables)
 12 Months Ended
Jun. 30, 2026
Stockholders' Equity Note [Abstract]  
Schedule of Activity of Restricted Stock Units
The following table summarizes the activity of RSUs and PRSUs during year ended June 30, 2026 (in thousands, except years and per share amounts):
Weighted Average Grant-Date
Fair Value
Weighted Average Remaining
Contractual Term in Years
Restricted
Stock
Units
Performance Restricted Stock Units
Restricted
Stock
Units
Performance Restricted Stock Units
Restricted
Stock
Units		Performance Restricted Stock Units
Outstanding at beginning of period833 342 $201.05 $213.28 1.51.5
Granted405 85 238.15 247.57 
Vested*(286)(80)202.61 213.08 
Forfeited (83)(30)202.54 211.33 
Outstanding at end of period869 317 $217.66 $220.43 1.41.5
*Includes approximately 62 thousand RSUs and 28 thousand PRSUs netted for tax.
Schedule of Option Activity
The following table summarizes option activity during the year ended June 30, 2026 (in thousands, except years and per share amounts):
OptionsWeighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Term in Years
Outstanding at beginning of period517 $175.61 2.7
Granted36 250.52 
Exercised*(205)136.82 
Forfeited(2)224.58 
Outstanding at end of period346 $206.02 3.2
Options exercisable at end of period265 $201.27 2.4
Options vested and expected to vest at end of period342 $205.65 3.1
*Includes approximately 8 thousand shares netted for tax.
Schedule of Assumptions for Fair Value of Stock Option Plans and Purchase Rights Granted
202620252024
Performance restricted stock units
Weighted average grant date fair value$263.31$272.47$168.14
Weighted average risk-free interest rate3.63%4.23%4.50%
Expected life in years
3 - 4
3 - 4
3 - 4
Dividend yield(1)
0.93% - 1.29%
0.88%1.29%
Expected volatility
32% - 33%
32% - 34%
31% - 36%
Average peer volatility(2)
30%31%31%
Average peer correlation coefficient(3)
0.43160.51890.5385
Stock options:
Weighted average grant date fair value$97.63$88.54$50.48
Weighted average risk-free interest rate3.80%4.17%4.44%
Expected life in years7.04.94.9
Dividend yield0.96%0.85%1.29%
Expected volatility35%37%36%
ESPP purchase rights:
Weighted average grant date fair value$52.87$59.55$47.40
Weighted average risk-free interest rate3.9%4.7%5.4%
Expected life in years0.50.50.5
Dividend yield
0.90% - 1.29%
0.87% - 0.90%
0.75% - 1.30%
Expected volatility
19% - 34%
34% - 39%
27% - 40%
(1)    The dividend yield used to project the value of the stock delivered to the holder is based on historical dividends and the expectation of future dividend payouts. Total stockholder return is determined assuming the reinvestment of dividends over the performance period, which is mathematically equivalent to a 0% dividend yield.
(2)    The correlation coefficients are based upon the stock price data used to estimate the volatility assumptions.
(3)    The average peer volatility is estimated based upon the historical volatility of each peer company.
Schedule of Total Stock-Based Compensation Costs Incurred and Associated Tax Benefit Recognized
The following table summarizes total stock-based compensation costs incurred and the associated tax benefit recognized during the years ended June 30, 2026, 2025 and 2024 (in thousands):
202620252024
Cost of sales $10,121 $8,945 $7,563 
Research and development expenses22,042 18,128 14,472 
Selling, general and administrative expenses72,185 64,588 58,149 
Stock-based compensation costs104,348 91,661 80,184 
Tax benefit(23,127)(21,833)(15,053)
Stock-based compensation costs, net of tax benefit$81,221 $69,828 $65,131